2023 was a troublesome calendar year for your biopharma marketplace, with a number of corporations downsizing and restructuring their workforces to remain afloat. You'll find signs of recovery, as mergers and acquisitions picked up over the pharmaceutical and lifetime sciences field in the latter A part of 2023 and have https://sites.google.com/view/bio-sites/blog